Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues

Magnachip Semiconductor: An Intriguing Stock On A Bad Streak

Intel: CEO Gelsinger Fulfilling The Goals While Reducing Uncertainty

2024’s Best & Worst States for Doctors – WalletHub Study

Credo Technology: Concentration Risk Still Overshadows Hyperscaler Progress

Pfizer: It’s Darkest Before The Dawn, Upgrading To ‘Strong Buy’

Amazon Stock May Be The Cheapest Mega Cap Right Now

Progress Software’s Balance Sheet Weakness Stands Out, But The Stock Looks Undervalued

2024’s Most Overweight and Obese Cities in the U.S. – WalletHub Study

Independence Pet Holdings Acquires Pets Best Insurance Services

The Beginning Of A New Era At Amazon

Broadcom Stock Is Expensive, But Worth It Long Term

Super Micro Computer Is Taking A Breath, The Run-Up Should Continue

Digital Turbine: Still High Uncertainty Despite New Overseas Partnerships

Pfizer Stock: It’s Time To Buy The Dip

Amazon: Jeff Is Selling, Maybe You Should Consider It Too